nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.225	0.426	CbGbCtD
Tolvaptan—ABCB1—Colchicine—primary biliary cirrhosis	0.19	0.359	CbGbCtD
Tolvaptan—CYP3A4—Colchicine—primary biliary cirrhosis	0.114	0.215	CbGbCtD
Tolvaptan—Disseminated intravascular coagulation—Colchicine—primary biliary cirrhosis	0.0175	0.0589	CcSEcCtD
Tolvaptan—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.0106	0.0643	CbGpPWpGaD
Tolvaptan—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00802	0.0488	CbGpPWpGaD
Tolvaptan—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00707	0.0238	CcSEcCtD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00652	0.0396	CbGpPWpGaD
Tolvaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—AQP4—primary biliary cirrhosis	0.00631	0.0383	CbGpPWpGaD
Tolvaptan—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00594	0.02	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00594	0.02	CcSEcCtD
Tolvaptan—AVPR2—Aquaporin-mediated transport—AQP4—primary biliary cirrhosis	0.0055	0.0335	CbGpPWpGaD
Tolvaptan—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00548	0.0333	CbGpPWpGaD
Tolvaptan—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00508	0.0171	CcSEcCtD
Tolvaptan—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00508	0.0171	CcSEcCtD
Tolvaptan—AVPR1A—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00501	0.0305	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.00498	0.0302	CbGpPWpGaD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00494	0.03	CbGpPWpGaD
Tolvaptan—Zafirlukast—ABCG2—primary biliary cirrhosis	0.00461	0.451	CrCbGaD
Tolvaptan—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00454	0.0153	CcSEcCtD
Tolvaptan—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00442	0.0269	CbGpPWpGaD
Tolvaptan—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00428	0.0144	CcSEcCtD
Tolvaptan—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00428	0.0144	CcSEcCtD
Tolvaptan—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00425	0.0143	CcSEcCtD
Tolvaptan—Dehydration—Colchicine—primary biliary cirrhosis	0.00422	0.0142	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00416	0.014	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00416	0.014	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00409	0.0138	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00408	0.0137	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00408	0.0137	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.004	0.0135	CcSEcCtD
Tolvaptan—Vismodegib—ABCG2—primary biliary cirrhosis	0.00391	0.382	CrCbGaD
Tolvaptan—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00382	0.0129	CcSEcCtD
Tolvaptan—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00382	0.0129	CcSEcCtD
Tolvaptan—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00379	0.0128	CcSEcCtD
Tolvaptan—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00379	0.0128	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00372	0.0125	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00372	0.0125	CcSEcCtD
Tolvaptan—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00368	0.0124	CcSEcCtD
Tolvaptan—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00368	0.0124	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00367	0.0124	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00367	0.0124	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0036	0.0121	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0036	0.0121	CcSEcCtD
Tolvaptan—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00326	0.011	CcSEcCtD
Tolvaptan—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00326	0.011	CcSEcCtD
Tolvaptan—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00315	0.0191	CbGpPWpGaD
Tolvaptan—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00309	0.0104	CcSEcCtD
Tolvaptan—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00309	0.0104	CcSEcCtD
Tolvaptan—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00283	0.00952	CcSEcCtD
Tolvaptan—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00279	0.00938	CcSEcCtD
Tolvaptan—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00279	0.00938	CcSEcCtD
Tolvaptan—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00933	CcSEcCtD
Tolvaptan—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00933	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00277	0.0168	CbGpPWpGaD
Tolvaptan—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00931	CcSEcCtD
Tolvaptan—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.00931	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00275	0.0167	CbGpPWpGaD
Tolvaptan—Malnutrition—Colchicine—primary biliary cirrhosis	0.00273	0.0092	CcSEcCtD
Tolvaptan—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00273	0.0166	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00881	CcSEcCtD
Tolvaptan—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00881	CcSEcCtD
Tolvaptan—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00861	CcSEcCtD
Tolvaptan—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.00861	CcSEcCtD
Tolvaptan—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00858	CcSEcCtD
Tolvaptan—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00255	0.00858	CcSEcCtD
Tolvaptan—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00856	CcSEcCtD
Tolvaptan—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00856	CcSEcCtD
Tolvaptan—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00827	CcSEcCtD
Tolvaptan—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00827	CcSEcCtD
Tolvaptan—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00242	0.0147	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00236	0.0143	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00234	0.0142	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00767	CcSEcCtD
Tolvaptan—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00767	CcSEcCtD
Tolvaptan—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00221	0.00745	CcSEcCtD
Tolvaptan—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00221	0.00745	CcSEcCtD
Tolvaptan—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00741	CcSEcCtD
Tolvaptan—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00741	CcSEcCtD
Tolvaptan—Shock—Colchicine—primary biliary cirrhosis	0.00219	0.00739	CcSEcCtD
Tolvaptan—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00219	0.00736	CcSEcCtD
Tolvaptan—Skin disorder—Colchicine—primary biliary cirrhosis	0.00217	0.00729	CcSEcCtD
Tolvaptan—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00216	0.00726	CcSEcCtD
Tolvaptan—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00216	0.00726	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.00214	0.013	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.00213	0.0129	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00212	0.0129	CbGpPWpGaD
Tolvaptan—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00208	0.0126	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00699	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00699	CcSEcCtD
Tolvaptan—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00695	CcSEcCtD
Tolvaptan—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00695	CcSEcCtD
Tolvaptan—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00688	CcSEcCtD
Tolvaptan—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00688	CcSEcCtD
Tolvaptan—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00664	CcSEcCtD
Tolvaptan—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00664	CcSEcCtD
Tolvaptan—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00662	CcSEcCtD
Tolvaptan—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00662	CcSEcCtD
Tolvaptan—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00655	CcSEcCtD
Tolvaptan—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00655	CcSEcCtD
Tolvaptan—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00194	0.00653	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00193	0.00648	CcSEcCtD
Tolvaptan—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00643	CcSEcCtD
Tolvaptan—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00643	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00185	0.0112	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00183	0.0111	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.00183	0.0111	CbGpPWpGaD
Tolvaptan—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00586	CcSEcCtD
Tolvaptan—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00586	CcSEcCtD
Tolvaptan—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00174	0.0106	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00173	0.00582	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00173	0.00582	CcSEcCtD
Tolvaptan—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00577	CcSEcCtD
Tolvaptan—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00577	CcSEcCtD
Tolvaptan—Vismodegib—ALB—primary biliary cirrhosis	0.0017	0.167	CrCbGaD
Tolvaptan—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00556	CcSEcCtD
Tolvaptan—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00556	CcSEcCtD
Tolvaptan—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00164	0.00553	CcSEcCtD
Tolvaptan—Asthenia—Colchicine—primary biliary cirrhosis	0.0016	0.00539	CcSEcCtD
Tolvaptan—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00533	CcSEcCtD
Tolvaptan—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00533	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00158	0.00961	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00157	0.00954	CbGpPWpGaD
Tolvaptan—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00153	0.00514	CcSEcCtD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00149	0.00906	CbGpPWpGaD
Tolvaptan—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00148	0.009	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00497	CcSEcCtD
Tolvaptan—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00497	CcSEcCtD
Tolvaptan—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00146	0.00887	CbGpPWpGaD
Tolvaptan—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00484	CcSEcCtD
Tolvaptan—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00484	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00144	0.00873	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00143	0.00866	CbGpPWpGaD
Tolvaptan—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00477	CcSEcCtD
Tolvaptan—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00477	CcSEcCtD
Tolvaptan—Headache—Colchicine—primary biliary cirrhosis	0.0014	0.0047	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00139	0.00845	CbGpPWpGaD
Tolvaptan—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00462	CcSEcCtD
Tolvaptan—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00462	CcSEcCtD
Tolvaptan—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.00133	0.00807	CbGpPWpGaD
Tolvaptan—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00446	CcSEcCtD
Tolvaptan—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00446	CcSEcCtD
Tolvaptan—Nausea—Colchicine—primary biliary cirrhosis	0.00132	0.00446	CcSEcCtD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.0013	0.00792	CbGpPWpGaD
Tolvaptan—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00423	CcSEcCtD
Tolvaptan—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00423	CcSEcCtD
Tolvaptan—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00122	0.00742	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.0012	0.00732	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.0012	0.00727	CbGpPWpGaD
Tolvaptan—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00401	CcSEcCtD
Tolvaptan—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00401	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.00111	0.00678	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.00111	0.00673	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.00109	0.00664	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.00109	0.0066	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.00096	0.00583	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000953	0.00579	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000921	0.0056	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.0009	0.00547	CbGpPWpGaD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000899	0.00546	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000882	0.00536	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000857	0.00521	CbGpPWpGaD
Tolvaptan—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000851	0.00518	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000817	0.00496	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000813	0.00494	CbGpPWpGaD
Tolvaptan—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000811	0.00493	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000803	0.00488	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000797	0.00484	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000795	0.00483	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.00078	0.00474	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.00076	0.00462	CbGpPWpGaD
Tolvaptan—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000758	0.00461	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000748	0.00455	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000742	0.00451	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000729	0.00443	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000727	0.00442	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000695	0.00423	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00068	0.00414	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000676	0.00411	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000666	0.00405	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000644	0.00391	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000639	0.00388	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000619	0.00376	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000618	0.00376	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000618	0.00376	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000613	0.00373	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000613	0.00373	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000569	0.00346	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000565	0.00344	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000561	0.00341	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000557	0.00339	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000544	0.00331	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000538	0.00327	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000535	0.00325	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000504	0.00306	CbGpPWpGaD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000499	0.00304	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000499	0.00303	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.00049	0.00298	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000487	0.00296	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000469	0.00285	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—AGT—primary biliary cirrhosis	0.00041	0.00249	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000407	0.00247	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000379	0.0023	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000376	0.00229	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000365	0.00222	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000365	0.00222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000362	0.0022	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000355	0.00216	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000355	0.00216	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000349	0.00212	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000331	0.00201	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000329	0.002	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000323	0.00196	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000322	0.00196	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00032	0.00194	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000307	0.00186	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000304	0.00185	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000292	0.00178	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.00029	0.00176	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000277	0.00168	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000275	0.00167	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000271	0.00165	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000267	0.00162	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000265	0.00161	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000252	0.00153	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.00025	0.00152	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	0.000242	0.00147	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000235	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000232	0.00141	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.00023	0.0014	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AGT—primary biliary cirrhosis	0.00021	0.00128	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000209	0.00127	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000173	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000171	0.00104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LBR—primary biliary cirrhosis	0.000163	0.000992	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000157	0.000957	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000157	0.000956	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000156	0.00095	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000156	0.00095	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000149	0.000903	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000148	0.000897	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000146	0.000888	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000145	0.00088	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000144	0.000875	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000143	0.000869	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000139	0.000843	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000127	0.000771	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000125	0.000758	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGT—primary biliary cirrhosis	0.000124	0.000756	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000124	0.000753	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGT—primary biliary cirrhosis	0.000123	0.00075	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	0.000118	0.000717	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000118	0.000717	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—primary biliary cirrhosis	0.00011	0.000669	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—primary biliary cirrhosis	0.000109	0.000665	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	0.000105	0.000639	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	0.000101	0.000611	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	9.89e-05	0.000601	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	9.89e-05	0.000601	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TYK2—primary biliary cirrhosis	9.3e-05	0.000565	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TYK2—primary biliary cirrhosis	9.23e-05	0.000561	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	8.81e-05	0.000535	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—primary biliary cirrhosis	7.32e-05	0.000445	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	7.27e-05	0.000442	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—primary biliary cirrhosis	7.27e-05	0.000442	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.24e-05	0.00044	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.19e-05	0.000437	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	6.48e-05	0.000394	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	6.09e-05	0.00037	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	6.09e-05	0.00037	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	5.94e-05	0.000361	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	5.53e-05	0.000336	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	4.74e-05	0.000288	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	4.7e-05	0.000286	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.61e-05	0.00028	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	4.06e-05	0.000247	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	4.06e-05	0.000247	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	3.66e-05	0.000223	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	3.61e-05	0.000219	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	3.4e-05	0.000207	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	2.92e-05	0.000178	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	2.9e-05	0.000176	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGT—primary biliary cirrhosis	2.81e-05	0.000171	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.5e-05	0.000152	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.5e-05	0.000152	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.22e-05	0.000135	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—primary biliary cirrhosis	2.16e-05	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.73e-05	0.000105	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.33e-05	8.08e-05	CbGpPWpGaD
